HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Crest Whitestrips Premium Offers Seven-Day Regimen At Higher Price

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

Procter & Gamble is keeping the pressure on competitors in the tooth-whitening market with the launch of an upgraded version of Crest Whitestrips. The product recently was introduced to retailers and is scheduled to be on counter in January

You may also be interested in...



Crest Whitestrips Extension Offers Long-Lasting Results, P&G Says

Crest Whitestrips Premium Plus offers effects similar to laser teeth whitening by dentists that last up to 18 months, according to Procter & Gamble

Crest Whitestrips Extension Offers Long-Lasting Results, P&G Says

Crest Whitestrips Premium Plus offers effects similar to laser teeth whitening by dentists that last up to 18 months, according to Procter & Gamble

Oral B/Rembrandt Strips Positioned As Fastest Tooth Whitener On The Market

Oral B/Rembrandt Whitening Strips whiten teeth in five days, making them the fastest such product in the mass market, according to Gillette

Table

View full table

Tags:
Latest Headlines

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In

Cosmetic And Personal Care Trademark Review: 16 April

Health And Wellness Weekly Trademarks Review: 16 April

See All
UsernamePublicRestriction

Register

RS011712

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By